1

Mini-antibodies Reactivate the p53 protein: A Potential Pathway for Malignant Treatment

News Discuss 
A major discovery in cancer research is occurring with the use of VHH fragments to re-engage dysfunctional p53. This crucial tumor suppressor protein is frequently inactivated in many types of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story